Securities Code: 300702 Securities Abbreviation: Tianyu Shares Announcement Number: 2026-046 Zhejiang Tianyu Pharmaceutical Co., Ltd. 2026 Second Extraordinary General Meeting Resolution Announcement The Company's Board of Directors and all Directors guarantee that this announcement contains no false statements, misleading representations or significant omissions, and they shall bear individual and joint legal responsibility for the authenticity, accuracy and completeness of its contents. Special Notes:
- There were no new, amended, or rejected proposals at this shareholders' meeting.
- This shareholders' meeting does not involve any changes to previous shareholders' meeting resolutions.
I. Meeting Convening and Attendance
- Meeting Session: 2026 Second Extraordinary General Meeting
- Meeting Convener: Company Board of Directors
- Date and Time of Meeting: (1) On-site Meeting Time: June 2, 2026 (Tuesday) 15:30 (2) Online Voting Time: Voting via Shenzhen Stock Exchange system was from June 2, 2026, 9:15-9:25, 9:30-11:30, 13:00-15:00; voting via internet voting system was from June 2, 2025, 9:15-15:00.
- Meeting Method: This shareholders' meeting adopted a combination of on-site voting and online voting.
- Meeting Location: First-floor conference room, Company Headquarters Building, No. 8 Xinyuan Road, Jiukou Chemical Industrial Park, Huangyan, Taizhou City.
- This meeting was convened by the Sixth Board of Directors of the Company and presided over by Director Ms. Lin Jie. As the Chairman of the Board was unable to preside over this meeting due to official duties, the presiding officer was jointly elected by more than half of the Directors in accordance with the "Articles of Association". Company Directors, senior management, witnessing lawyers, and other relevant personnel attended or were present at this meeting. The convening of this shareholders' meeting complied with relevant laws, administrative regulations, departmental rules, normative documents, and the Company's Articles of Association.
- A total of 83 shareholders and authorized representatives attended this shareholders' meeting, representing 184,006,194 shares, accounting for 52.8788% of the company's total share capital. Among them, 5 shareholders and authorized representatives attended the on-site meeting, representing 179,279,154 shares, accounting for 51.5204% of the company's total share capital. A total of 78 shareholders and authorized representatives participated in the online voting, representing 4,727,040 shares, accounting for 1.3584% of the company's total share capital. A total of 79 small and medium investors participated in this shareholders' meeting through on-site and online voting, representing 4,729,340 shares, accounting for 1.3591% of the company's total share capital.
II. Deliberation and Voting on Proposals
This shareholders' meeting deliberated and voted on the following proposal using a combination of on-site and online voting: 1.00. Approved the Proposal on "Changing the Use of Some Raised Funds and Adding New Investment Projects for Raised Funds".